Molecular Pathways: Regulation and Therapeutic Implications of Multidrug Resistance

par Chen, Kevin G., Sikic, Branimir I.
Publié 2012

The Syk inhibitor R406 is a modulator of P-glycoprotein (ABCB1)-mediated multidrug resistance

par Duran, George E., Sikic, Branimir I.
Publié dans PLoS One (2019)

Rapid determination of PEGylated liposomal doxorubicin and its major metabolite in human plasma by ultraviolet–visible high-performance liquid chromatography

par Chin, David L., Lum, Bert L., Sikic, Branimir I.
Publié 2002

Identification of ovarian cancer driver genes by using module network integration of multi-omics data

par Gevaert, Olivier, Villalobos, Victor, Sikic, Branimir I., Plevritis, Sylvia K.
Publié 2013

Identification of ovarian cancer driver genes by using module network integration of multi-omics data

par Gevaert, Olivier, Villalobos, Victor, Sikic, Branimir I., Plevritis, Sylvia K.
Publié 2014

Evidence of a Role for Functional Heterogeneity in Multidrug Resistance (MDR) Transporters in Clinical Trials of P-glycoprotein Modulation in Acute Myeloid Leukemia

par Marcelletti, John F., Sikic, Branimir I., Cripe, Larry D., Paietta, Elisabeth
Publié dans Cytometry B Clin Cytom (2018)

Clinical trial designs for testing biomarker-based personalized therapies

par Lai, Tze Leung, Lavori, Philip W, Shih, Mei-Chiung I, Sikic, Branimir I
Publié dans Clin Trials (2012)

The miR‐200 family differentially regulates sensitivity to paclitaxel and carboplatin in human ovarian carcinoma OVCAR‐3 and MES‐OV cells

par Brozovic, Anamaria, Duran, George E., Wang, Yan C., Francisco, E. Brian, Sikic, Branimir I.
Publié dans Mol Oncol (2015)

Decreased levels of baseline and drug-induced tubulin polymerisation are hallmarks of resistance to taxanes in ovarian cancer cells and are associated with epithelial-to-mesenchyma...

par Duran, George E, Wang, Yan C, Moisan, François, Francisco, E Brian, Sikic, Branimir I
Publié dans Br J Cancer (2017)

Expression and silencing of microtubule-associated protein Tau in breast cancer cells

par Spicakova, Tatiana, O’Brien, Maureen M., Duran, George E., Sweet-Cordero, Alejandro, Sikic, Branimir I.
Publié 2010

Single Gene Prognostic Biomarkers in Ovarian Cancer: A Meta-Analysis

par Willis, Scooter, Villalobos, Victor M., Gevaert, Olivier, Abramovitz, Mark, Williams, Casey, Sikic, Branimir I., Leyland-Jones, Brian
Publié dans PLoS One (2016)

A method for detecting and correcting feature misidentification on expression microarrays

par Brown Patrick O, Sikic Branimir I, Diehn Maximilian, Schaner Marci, Tu I-Ping, Botstein David, Fero Michael J
Publié 2004-09-01

A method for detecting and correcting feature misidentification on expression microarrays

par Tu, I-Ping, Schaner, Marci, Diehn, Maximilian, Sikic, Branimir I, Brown, Patrick O, Botstein, David, Fero, Michael J
Publié 2004

A Phase II Study of Gefitinib, 5-Fluorouracil, Leucovorin, and Oxaliplatin (IFOX) in Previously Untreated Patients with Metastatic Colorectal Cancer

par Fisher, George A., Kuo, Timothy, Ramsey, Meghan, Schwartz, Erich, Rouse, Robert V., Cho, Cheryl D., Halsey, Joanne, Sikic, Branimir I.
Publié 2008

Chromatin-remodeling complex SWI/SNF controls multidrug resistance by transcriptionally regulating the drug efflux pump ABCB1

par Dubey, Ramin, Lebensohn, Andres, Bahrami-Nejad, Zahra, Marceau, Caleb, Champion, Magali, Gevaert, Olivier, Sikic, Branimir I., Carette, Jan E., Rohatgi, Rajat
Publié dans Cancer Res (2016)

Gene expression profiling differentiates germ cell tumors from other cancers and defines subtype-specific signatures

par Juric, Dejan, Sale, Sanja, Hromas, Robert A., Yu, Ron, Wang, Yan, Duran, George E., Tibshirani, Robert, Einhorn, Lawrence H., Sikic, Branimir I.
Publié 2005

Amplification of Whole Tumor Genomes and Gene-by-Gene Mapping of Genomic Aberrations from Limited Sources of Fresh-Frozen and Paraffin-Embedded DNA

par Bredel, Markus, Bredel, Claudia, Juric, Dejan, Kim, Young, Vogel, Hannes, Harsh, Griffith R., Recht, Lawrence D., Pollack, Jonathan R., Sikic, Branimir I.
Publié 2005

Mechanisms of Resistance to Cabazitaxel

par Duran, George E., Wang, Yan C., Francisco, E. Brian, Rose, John C., Martinez, Francisco J., Coller, John, Brassard, Diana, Vrignaud, Patricia, Sikic, Branimir I.
Publié dans Mol Cancer Ther (2014)

Enhancement of paclitaxel and carboplatin therapies by CCL2 blockade in ovarian cancers

par Moisan, Francois, Francisco, Edgar B., Brozovic, Anamaria, Duran, George E., Wang, Yan C., Chaturvedi, Shalini, Seetharam, Shobha, Snyder, Linda A., Doshi, Parul, Sikic, Branimir I.
Publié dans Mol Oncol (2014)

Safety and activity of varlilumab, a novel and first-in-class agonist anti-CD27 antibody, for hematologic malignancies

par Ansell, Stephen M., Flinn, Ian, Taylor, Matthew H., Sikic, Branimir I., Brody, Joshua, Nemunaitis, John, Feldman, Andrew, Hawthorne, Thomas R., Rawls, Tracey, Keler, Tibor, Yellin, Michael J.
Publié dans Blood Adv (2020)